Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
09:00am, Wednesday, 20'th Mar 2024
REHOVOT, Israel , March 20, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company targeting to revolutionize life-science pro
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
09:00am, Tuesday, 19'th Mar 2024
REHOVOT, Israel , March 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products an
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America
09:00am, Wednesday, 13'th Mar 2024
REHOVOT, Israel , March 13, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products a
Evogene Ltd. (EVGN) Q4 2023 Earnings Call Transcript
01:35pm, Thursday, 07'th Mar 2024
Evogene Ltd. (NASDAQ:EVGN ) Q4 2023 Results Conference Call March 7, 2024 9:00 AM ET Company Participants Ofer Haviv - President and Chief Executive Officer Yaron Eldad - Chief Financial Officer Yoash
Evogene (EVGN) Reports Q4 Loss, Misses Revenue Estimates
10:21am, Thursday, 07'th Mar 2024
Evogene (EVGN) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.07 per share a year ago.
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
07:00am, Thursday, 07'th Mar 2024
Conference call and webcast: today, March 7, 2024, 9:00 am E.T. +1-888-407-2553 or +972-3- 9180608 I https://veidan.activetrail.biz/evogeneq4-2023 REHOVOT, Israel , March 7, 2024 /PRNewswire/ -- Evoge
The new agreements are expected to support additional production of approximately 400 tons of Casterra's elite castor seeds in 2024 and establish long-term production infrastructure REHOVOT, Israel ,
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
07:00am, Wednesday, 28'th Feb 2024
The payment completes the $5M advance payment received under the licensing agreement for bio-fungicide product candidates REHOVOT, Israel , Feb. 28, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
07:00am, Monday, 26'th Feb 2024
Conference call scheduled for 9:00 AM ET REHOVOT, Israel , Feb. 26, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize l
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
07:00am, Thursday, 22'nd Feb 2024
REHOVOT, Israel , Feb. 22, 2024 /PRNewswire/ -- AgPlenus Ltd, a global leader in designing and developing novel sustainable crop protection products, and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
07:00am, Wednesday, 21'st Feb 2024
The collaboration will tap into the potential of artificial intelligence (AI) to design and optimize crop protection chemistry, developing a novel sustainable Mode-of-Action (MoA) broad-spectrum herbi
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
07:00am, Tuesday, 20'th Feb 2024
Agreement reinforces both companies' commitment to developing and bringing innovative biological solutions to farmers BASEL, Switzerland and REHOVOT, Israel , Feb. 20, 2024 /PRNewswire/ -- Syngenta Cr
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
07:08am, Tuesday, 06'th Feb 2024
The parties will identify and design probiotic bacteria that produce highly sustainable quantities of microbial metabolites, known to improve human health and vitality BOSTON and REHOVOT, Israel , Feb
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
07:00am, Tuesday, 23'rd Jan 2024
REHOVOT, Israel , Jan. 23, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.
Here's Why Evogene (EVGN) is a Great Momentum Stock to Buy
01:32pm, Friday, 12'th Jan 2024
Does Evogene (EVGN) have what it takes to be a top stock pick for momentum investors? Let's find out.
